NCT03392532

Brief Summary

The purpose of this research study is to compare the performance of two different types of Alcon soft toric study contact lenses to obtain information on study lens orientation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

January 4, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 8, 2018

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2018

Completed
1 year until next milestone

Results Posted

Study results publicly available

January 29, 2019

Completed
Last Updated

January 29, 2019

Status Verified

January 1, 2019

Enrollment Period

22 days

First QC Date

January 2, 2018

Results QC Date

January 7, 2019

Last Update Submit

January 7, 2019

Conditions

Keywords

AstigmatismAxis orientation

Outcome Measures

Primary Outcomes (1)

  • Percentage of Lenses With Axis Orientation Within ±30 Degrees From the 90 Degree Axis (Ideal Location)

    Each lens was classified based on whether the absolute difference between the axis location and 90° was less than or equal to 30° (ie, lens axis located between the 60° and 120° axis inclusive). Inferential testing was not planned for this primary effectiveness endpoint.

    Day 1, 10 minutes after lens insertion, each product

Study Arms (2)

AOHG toric, then AO toric

OTHER

Lotrafilcon B toric contact lenses with HYDRAGLYDE, followed by lotrafilcon B toric contact lenses, as randomized. Each product worn in both eyes for approximately 30 minutes, with a 30-45 minute washout between the removal of Pair 1 and insertion of Pair 2.

Device: Lotrafilcon B toric contact lenses with HYDRAGLYDEDevice: Lotrafilcon B toric contact lenses

AO toric, then AOHG toric

OTHER

Lotrafilcon B toric contact lenses, followed by lotrafilcon B toric contact lenses with HYDRAGLYDE, as randomized. Each product worn in both eyes for approximately 30 minutes, with a 30-45 minute washout between the removal of Pair 1 and insertion of Pair 2.

Device: Lotrafilcon B toric contact lenses with HYDRAGLYDEDevice: Lotrafilcon B toric contact lenses

Interventions

Silicone hydrogel soft contact lenses for astigmatism

Also known as: AIR OPTIX® plus HYDRAGLYDE® for Astigmatism contact lenses, AOHG for Astigmatism
AO toric, then AOHG toricAOHG toric, then AO toric

Silicone hydrogel soft contact lenses for astigmatism

Also known as: AIR OPTIX® for Astigmatism contact lenses, AO for Astigmatism
AO toric, then AOHG toricAOHG toric, then AO toric

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Successful wear of soft contact lenses for vision correction in both eyes during the past 3 months for a minimum of 3 days per week and 8 hours per day
  • Astigmatism
  • Requires contact lenses
  • Best corrected visual acuity of 20/25 or better in each eye

You may not qualify if:

  • Any eye condition that contraindicates contact lens wear, as determined by the Investigator
  • Any eye surgery that contraindicates contact lens wear, as determined by the Investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alcon Investigative Site

Johns Creek, Georgia, 30097, United States

Location

MeSH Terms

Conditions

Astigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
CDMA Project Lead, CDMA Vision Care
Organization
Alcon, A Novartis Division

Study Officials

  • Alcon, A Novartis Division

    Alcon, A Novartis Division

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2018

First Posted

January 8, 2018

Study Start

January 4, 2018

Primary Completion

January 26, 2018

Study Completion

January 26, 2018

Last Updated

January 29, 2019

Results First Posted

January 29, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations